Kanał RARE
RA
Ultragenyx Pharmaceutical
RARE · NASDAQ
$27.65 -3.44% (-$0.98)
1M +1.81%
Market Cap $2.7B
P/E Ratio -
Div. Yield -
ROE 411.04%
Bulios Fair Price
$164.1
493.6% upside
Aktualna cena
$27.65
Niedowartościowane Wartość godziwa Przewartościowane
Valuation
10 /100
Expensive P/B 297.27x
P/S 4.05x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 22.81%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 0.00%
Op. margin 0.00%
FCF margin 0.00%
Quality
0 /100
Poor ROE 0.00%
ROA 0.00%
Asset turnover 0.57x
Debt
43 /100
Moderate Current ratio 1.89x
Int. coverage -8.37x
Net debt/EBITDA -1.35x
Stability
61 /100
Moderate Rev. volatility 5.31%
EPS volatility 8.40%
Profitable years 0
Zapytaj StockBota o RARE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Emil D. Kakkis
Employees
1,371
Headquarters
Novato
Nadchodzące wydarzenia
04 SIE
Earnings
Upcoming earnings report